BRIGHT-DATA
12.9.2022 15:23:36 CEST | Business Wire | Press release
Bright Data, the industry-leading web data platform, has today announced the acquisition of eCommerce insights provider Market Beyond. With this acquisition, Bright Data adds digital shelf analytics to its already comprehensive data offerings, introducing its new division – Bright Insights.
Market Beyond’s team will join Bright Data’s 400+-strong team, where they will lead the newly established Bright Insights division. This dedicated team will roll out Bright Insights to the company’s enterprise retail customer base with plans to expand in the future to further domains.
Through Bright Insights, leading retail brands, marketplaces and manufacturers will now be able to gain quality, reliable web data as well as critical business insights from one place. This will allow prominent brands to create strategies based on quality-driven data insights and, in turn, optimize and advance their business performance.
Since launching in Tel Aviv, Israel, in 2016, Market Beyond has worked with large manufacturers and brands within the eCommerce sphere to provide an accurate picture of both their and their competitors’ market share in the eCommerce landscape. Market Beyond has grown significantly and now has a global footprint with a dedicated US focus, where its customer base includes multiple Fortune 500 brands, such as Home Depot, eBay, Overstock and many more.
“The acquisition of Market Beyond, and the subsequent launch of Bright Insights, will allow retail sphere leaders to seamlessly get the real-time web data they need as well as the actionable insights crucial for split-second decision-making,” said Bright Data CEO Or Lenchner. “Bright Data’s focus on innovating web data products supports thousands of customers around the world. The introduction of Bright Insights will take data analysis to the next level. We look forward to welcoming the Market Beyond team into Bright Data's expanding family, and we are excited about the positive impact this will have on the data industry,” concluded Lenchner.
“This partnership not only signals a new chapter for Market Beyond but affirms our commitment to providing market-leading data-driven insights to leading businesses around the world,” said Market Beyond CEO Yuval Yifrach. “Market Beyond’s capabilities complement Bright Data’s industry-first technology perfectly. This deal, as well as the launch of Bright Insights, will allow us to continue providing market intelligence to brands and retailers and extend our reach to new markets. We have been working closely with Bright Data’s technology for over two years and we look forward to continuing to work alongside the entire Bright Data team as we create Bright Insights and push the boundaries of what is possible within the data-driven analysis space.”
-ENDS-
About Market Beyond
Since its establishment in 2016, Market Beyond’s unique AI & Machine Learning technology has served the largest brands across the world, specifically the market-leading brands, Fortune 500 included, in the US. Today, Market Beyond provides its dozens of customers in the retail space with reliable and precise real-time market insights that directly impact their present landscape as well as future strategic steps.
About Bright Data
Bright Data is the industry-leading web data platform. Fortune 500 companies, academic institutions, and small businesses rely on Bright Data’s solutions to retrieve public web data in the most efficient, reliable, and flexible way so they can research, monitor, and train their systems and analyze data to run better strategies and inform decision-making.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005571/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom